Integration of the Wörtz-Gupta™ Formula into ZEISS VERACITY Surgery Planner Testifies to Its Ever-Improving Nature

1 June 2023
About the expert

Gary Wörtz, MD

Dr. Wörtz is a cataract and refractive surgeon at Commonwealth Eye Surgery in Lexington, Kentucky. He is also the founder and chief medical officer at Omega Ophthalmics.

ZEISS VERACITY Surgery Planner, one of the most significant innovations to enter the OR in the past several years, is a digital platform that aggregates various presurgical datasets (whether captured on ZEISS devices or not) into a centralized hub. ZEISS VERACITY Surgery Planner doesn’t declare surgical solutions or make judgment calls for surgeons. Rather, it collates data in a single place, freeing us to reconcile and interpret data from various sources without burdening ourselves and our staff with logistical tasks that distract from surgery.
Gone are the inefficiencies and clutter of paper printouts, as well as the attendant transcription errors. For ZEISS VERACITY Surgery Planner users, a digital solution to analog inefficiencies streamlines surgery, focuses attention on the patient rather than on logistics, and maximizes the value of presurgical data capture — all in the service of providing the best potential outcomes for the patients who trust us with their vision.
A real-world example illustrates the utility of ZEISS VERACITY Surgery Planner. Before I integrated it into my practice, adjustments to new conditions during surgery were cumbersome. If I needed to, say, slightly increase the power of a lens based on intraoperative observations, I had to run recalculations on one machine, transfer those findings to proper documentation on a second platform, ensure proper transcription occurred, and print out a new surgical plan. With ZEISS VERACITY Surgery Planner, real-time creation of a new surgical plan is done with a few taps of a screen. I remain efficient, confident in my surgical plan, and focused on the patient.
Perhaps the most impressive element of ZEISS VERACITY Surgery Planner is one directed by its creator: to continually improve, remain conducive to new programming, and expose surgeons to innovative surgical approaches. I recently had the privilege of contributing information that enhances ZEISS VERACITY Surgery Planner when the Wörtz-Gupta ™ Formula — which I created with my colleague Preeya Gupta, MD — was added to the formula offerings in ZEISS VERACITY Surgery Planner.
We created the Wörtz-Gupta ™ Formula to optimize femtosecond laser parameters for surgeons using arcuate incisions to address low levels of astigmatism. Although some existing formulas could already be used for this purpose, they were created when manual arcuate incisions were the norm. Contemporary surgeons using those older formulas often estimated adjustments to the formula to reflect their use of femtosecond laser. For surgeons seeking a more precise approach, an update was needed.
ZEISS added the Wörtz-Gupta ™ Formula to ZEISS VERACITY Surgery Planner to expand the platform’s capabilities. After users indicate that they are using femtosecond laser and need to create arcuate incisions to address low-level astigmatism, they select which formula they wish to use from a drop-down menu. Surgeons can toggle between formulas and see how it affects their surgical plan before deciding which option is best for their patient. These real-time updates to a surgical plan based on variables such as a formula adjustment allow surgeons to efficiently evaluate various approaches.
ZEISS VERACITY Surgery Planner will continue to integrate new features with future updates, and I expect this digital platform to familiarize me with various surgical innovations and novel approaches. If you’re a surgeon who keeps tabs on the vanguard of innovation, consider whether ZEISS VERACITY Surgery Planner would be a fit for your cutting-edge surgical suite.

Wörtz-Gupta is a registered trademark of Arcuate Innovations.
The statements of the author reflect only his personal opinions and do not necessarily reflect the opinions of any institution with whom he is affiliated.
The author has a contractual or other financial relationship with Carl Zeiss Meditec, Inc. and has received financial support.

Share this article